Antibodies

577 papers and 8.6k indexed citations i.

About

The 577 papers published in Antibodies in the last decades have received a total of 8.6k indexed citations. Papers published in Antibodies usually cover Radiology, Nuclear Medicine and Imaging (310 papers), Molecular Biology (244 papers) and Immunology (201 papers) specifically the topics of Monoclonal and Polyclonal Antibodies Research (306 papers), Glycosylation and Glycoproteins Research (95 papers) and Protein purification and stability (81 papers). The most active scholars publishing in Antibodies are David J. Zahavi, Louis M. Weiner, Gary L. Gilliland, Mark L. Chiu, Dennis R. Goulet, Darja Kanduc, A. Teplyakov, Adam Bates, Patrícia de Sousa-Pereira and Jenny M. Woof.

In The Last Decade

Fields of papers published in Antibodies

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Antibodies. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Antibodies

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Antibodies. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Antibodies with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025